Zidovudine and red-cell distribution width [7]

New England Journal of Medicine

Volumn 352, Issue 20, 2005, Pages 2141-2142

  Rivas, Pablo ^a   Górgolas, Miguel ^a   Fernández Guerrero, Manuel L ^a  

^a Instituto Reina Sofía de Investigación Nefrológica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; ZIDOVUDINE;

FOLLOW UP; HEMOGLOBIN ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MEAN CORPUSCULAR VOLUME; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; ERYTHROCYTE INDICES; ERYTHROCYTES; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; ZIDOVUDINE;

EID: 18644384023     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200505193522023     Document Type: Letter

References (4)

1. Snower DP, Weil SC. Changing etiology of macrocytosis: zidovudine as a frequent causative factor. Am J Clin Pathol 1993;99:57-60.
2. Romanelli F, Empey K, Pomeroy C. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care STDS 2002;16:405-11.
3. Steele RH, Keogh GL, Quin J, Fernando SL, Stojkova V. Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): a surrogate marker for adherence. Int J STD AIDS 2002;13:748-54.
4. Altice FL, Friedland GH. The era of adherence to HIV therapy. Ann Intern Med 1998;129:503-5.